Global Head of Clinical Pharmacology & Translational Medicine
Certara
Raleigh, North Carolina
Julie Bullock, PharmD is currently the Senior Vice President and Global Head of Clinical Pharmacology & Translational Medicine at Certara. She has over 17 years of drug development experience and is a recognized drug development scientist with clinical pharmacology and regulatory experience focused in the therapeutic areas of hematology/oncology and coagulation. Julie has extensive experience in all development phases including regulatory interactions with major global health authorities (FDA, EMA, PMDA), due diligence, design of clinical development approaches, pediatrics, dose-finding strategy and streamlining development for breakthrough therapies and accelerated approval.
In her current role, Dr. Bullock supports a global team of clinical pharmacologists, regulatory strategy and drug development scientists who create value for clients across the drug development ecosystem and ultimately accelerate patients’ access to medicines. Prior to her role at Certara Julie was the Clinical Pharmacology Team Leader for the Hematology/Oncology review team in the Office of Clinical Pharmacology/CDER/FDA. Julie’s FDA career spanned 10 years where she contributed to over 14 new molecular entity NDA/BLA filing applications, multiple supplemental NDA/BLA applications, countless IND related submissions. Dr. Bullock received her PharmD from Drake University and completed a clinical pharmacology drug development fellowship with the SUNY at Buffalo and Novartis Pharmaceuticals.
Disclosure information not submitted.
Tuesday, October 18, 2022
1:30 PM – 2:30 PM ET